Tivic health expands clinical study of post-operative pain in nasal and sinus surgeries

San francisco--(business wire)--tivic health® systems, inc. (“tivic”, nasdaq: tivc), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has expanded its post-operative pain clinical study to include otolaryngology and facial plastic surgery patients. this study aims to investigate the potential benefits of a drug-free alternative to traditional post-operative pain management methods.
TIVC Ratings Summary
TIVC Quant Ranking